Subscribe to MDT Magazine News

Affymetrix says judge dismisses Illumina lawsuits

December 15, 2010 3:46 am | by The Associated Press | Comments

Genetic testing instrument maker Affymetrix Inc. said Wednesday a federal judge dismissed patent infringement lawsuits brought by rival Illumina Inc.Affymetrix said the U.S. District Court for the Western District of Wisconsin found in its favor, and the lawsuits will be dismissed. Illumina had...

DSM Expands Industrial Biocatalysis Platform With c-LEcta Agreement

December 14, 2010 10:34 pm | by Bio-Medicine.Org | Comments

PARSIPPANY, N.J. and LEIPZIG, Germany, Dec. 15 2010 /- DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, today announces a license agreement with c-LEcta GmbH for proprietary screening technology. The agreement grants DSM rights to c-LEcta's proprietary...


STATS ChipPAC reports over 50% growth in flip chip business with more than 250 million units shipped in 2010

December 14, 2010 8:32 pm | by I-Micronews | Comments

ChipPAC Ltd. ("STATS ChipPAC" or the "Company") (SGX-ST: STATSChP), a leading semiconductor test and advanced packaging service provider, today announced that its flip chip business has grown more than 50% in 2010 compared to 2009. During 2010, shipments of flip chip packages have...


An Old Head May Not Be Wiser

December 14, 2010 7:34 pm | by Massachusetts Institute of Technology | Comments

Brain imaging and economic research suggest that older people make less predictable decisions about money.

Calif. regulator to insurer: Keep $120M for fines

December 14, 2010 1:45 pm | by The Associated Press | Comments

A California regulator is taking the unprecedented step of ordering PacifiCare Life and Health Insurance to keep $120 million in profits in the state to help pay up to $1 billion in possible fines for mishandling claims of policyholders.Insurance Commissioner Steve Poizner ordered the insurer...

Thermo Fisher names Chai to board

December 14, 2010 12:45 pm | by The Associated Press | Comments

Scientific instrument maker Thermo Fisher Scientific Inc. said Tuesday it elected Nelson J. Chai to its board of directors, bringing the company's total number of directors to 11.Chai is the executive vice president, chief administrative officer and head of strategy for CIT Group, a bank...

Tessalon (benzonatate): Drug Safety Communication - Potential for Accidental Ingestion by Children

December 14, 2010 11:31 am | by U.S. Food & Drug Administration | Comments

Benzonatate drug label being revised to warn about accidental ingestion, resulting in overdose and death, in children below age 10 years.

Charles River Labs plans to shed two facilities

December 14, 2010 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Charles River Laboratories International Inc., the Wilmington-based pharmaceutical and biotech services company, said it plans to seek "strategic alternatives" for a U.S. Phase 1 research clinic and a pre-clinical research facility in China.


Vaccine boosts your immune system

December 14, 2010 9:38 am | by EurekAlert | Comments

(University of Copenhagen) Researchers at BRIC, the University of Copenhagen, have discovered for the first time a protein normally found in the body that can act to prevent chronic tissue inflammation. When administered in the form of a therapeutic vaccine it is able to...


Allergy treatment may cause new allergy

December 14, 2010 9:38 am | by EurekAlert | Comments

(Lund University) Allergic contact dermatitis from aluminium has previously been considered very unusual. However, there are now reports of pruritic nodules and aluminium allergy arising after vaccinations or treatments for allergies. Researcher Eva Netterlid has studied the...


Tolerx launches Phase 1 trial of cancer treatment

December 14, 2010 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge biotech Tolerx Inc. said today that it has initiated a Phase 1 clinical trial of its TRX518, a therapy designed to enhance the immune system by enabling T cells to be more effective in attacking cancer cells.

Biotech startup Tesaro lands licensing deal for cancer treatment

December 14, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Tesaro Inc. has signed a deal with Miami-based OPKO Health Inc. that will bring the Boston firm exclusive rights to develop, manufacture, commercialize and distribute rolapitant, a cancer-related treatment, in return for up to $121 million in payments to OPKO.

Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011

December 14, 2010 9:35 am | by Bio-Medicine.Org | Comments

NEW YORK, Dec. 14, 2010  /- announces that a new market research report is available in its catalogue: European Markets for Video, High-Tech and Integrated OT Equipment 2011...


Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Staging and Prostate Cancer Recurrence Study

December 14, 2010 9:35 am | by Bio-Medicine.Org | Comments

NEW YORK, Dec. 14, 2010 /- A new study in the journal Cancer shows that staging prostate cancer that has not metastasized beyond the prostate gland does predict the outcome, prognosis or risk of cancer recurrence after a radical prostatectomy. "This study confirms what many prostate...


UBM Canon Launches Medical Manufacturing Events in India and Brazil

December 14, 2010 9:35 am | by Bio-Medicine.Org | Comments

LOS ANGELES, Dec. 14, 2010 /- UBM Canon today announced medical manufacturing event plans for two fast-growth BRIC markets, India and Brazil, utilizing respectively its long established MEDTEC and Medical Design & Manufacturing (MD&M) brands. In October 19-20, 2011, the MEDTEC...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.